Expected wait times for access to a disease-modifying Alzheimer’s treatment in England: A modelling study
This is my archive
Current Capacity for Diagnosing Alzheimer’s Disease in Germany and Implications for Wait Times
Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers
Estimated Investment Need to Increase England’s Capacity to Diagnose Eligibility for an Alzheimer’s Treatment to G7 Average Capacity Levels
Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers
Projected Savings to Canadian Provincial Budgets from Reduced Long-Term Care Home Utilization Due to a Disease-Modifying Alzheimer’s Treatment
Expected wait times for access to a disease-modifying Alzheimer’s treatment in England: A modelling study
Preparedness of China’s health care system to provide access to a disease-modifying Alzheimer’s treatment
Projected Ontario budget savings from reduced long-term care utilization due to a disease-modifying Alzheimer’s treatment
Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer’s disease treatment
